BioNxt Solutions Inc. (CVE:BNXT)

PRESS RELEASE

published on 08/04/2026 at 09:05, 3 months 5 days ago

BioNxt Provides Development, Intellectual Property and Commercial Update Across Sublingual Drug Delivery Pipeline
BioNxt Solutions Inc. provides update on proprietary drug delivery pipeline focusing on Cladribine for MS, autoimmune diseases, Everolimus, Semaglutide. Strengthening IP portfolio

BioNxt Solutions Inc. Intellectual Property Autoimmune Diseases Cladribine Drug Delivery Pipeline
BRIEF

published on 08/01/2026 at 00:30, 3 months 9 days ago

BioNxt Solutions émet de nouvelles options d'achat d'actions

Acquisition Options D'achat D'actions Solutions BioNxt Plan D'options Bourse Canadienne Des Valeurs Mobilières
BRIEF

published on 08/01/2026 at 00:30, 3 months 9 days ago

BioNxt Solutions Issues New Stock Options

Stock Options Canadian Securities Exchange Vesting BioNxt Solutions Option Plan
PRESS RELEASE

published on 08/01/2026 at 00:25, 3 months 9 days ago

BioNxt Solutions Announces Option Grants
BioNxt Solutions Inc. announces stock options grants under Option Plan to insiders, consultants, and employees. Focus on drug delivery innovations and cancer treatment platforms

Stock Options Cancer Treatment Innovations BioNxt Solutions Inc. Drug Delivery
BRIEF

published on 07/06/2026 at 09:10, 4 months 3 days ago

BioNxt Progresses with Sublingual Semaglutide ODF Development

Drug Delivery Pharmaceutical Development BioNxt Solutions Sublingual ODF GLP-1 Therapeutics
BRIEF

published on 07/06/2026 at 09:10, 4 months 3 days ago

BioNxt progresse dans le développement de l'ODF sublinguale de sémaglutide.

Développement Pharmaceutique Solutions BioNxt Administration De Médicaments ODF Sublingual Thérapeutiques GLP-1
PRESS RELEASE

published on 07/06/2026 at 09:05, 4 months 3 days ago

BioNxt Advances GLP-1 Sublingual Semaglutide ODF Program with Next Stage of Delivery Development Underway
BioNxt Solutions Inc. announces progress in Semaglutide oral dissolvable film program for GLP-1 therapies, expanding into a rapidly growing pharmaceutical market

BioNxt Solutions Inc. Pharmaceutical Market Oral Dissolvable Film GLP-1 Therapies Semaglutide
BRIEF

published on 06/23/2026 at 23:25, 4 months 16 days ago

BioNxt Solutions Completes $2M Non-brokered Private Placement

Private Placement Securities Warrants Investments BioNxt Solutions
BRIEF

published on 06/23/2026 at 23:25, 4 months 16 days ago

BioNxt Solutions finalise un placement privé sans intermédiaire de 2 millions de dollars

Placement Privé Investissements Titres Mandats Solutions BioNxt
PRESS RELEASE

published on 06/23/2026 at 23:20, 4 months 16 days ago

BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
BioNxt Solutions Inc. closes non-brokered private placement of units, plans to use proceeds for research and operations in Europe. Company updates on unsecured convertible debentures extension

Private Placement BioNxt Solutions Inc. Debt Extension European Research Bioscience Innovator

Published on 11/10/2026 at 02:45, 9 minutes ago

Presentation to Zurich Precious Metals Summit
Published on 11/09/2026 at 23:10, 3 hours 44 minutes ago

Ur-Energy Reports Third Quarter 2026 Results
Published on 11/09/2026 at 23:00, 3 hours 54 minutes ago

LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/09/2026 at 22:32, 4 hours 22 minutes ago

Announces Extension for Closing of Private Placement of Convertible Promissory Notes
Published on 11/09/2026 at 22:15, 4 hours 39 minutes ago

Goldcliff Announces Closing of the Second and Final Tranche of its "LIFE" Offering and Completion of Drilling at Kettle Valley

View all ACCESSWIRE

Published on 11/10/2026 at 01:20, 1 hour 33 minutes ago

US defence customer steps up orders and first graphene oxide orders secured
Published on 11/09/2026 at 23:35, 3 hours 18 minutes ago

KPS to Acquire MM Packaging from MM Group
Published on 11/09/2026 at 22:54, 3 hours 59 minutes ago

EQS-Adhoc: Northern Data Group reports Q3 2026 and raises its FY 2026 revenue outlook communicated on 17 June 2026
Published on 11/09/2026 at 22:10, 4 hours 43 minutes ago

Quantinuum to Participate in the Cantor Convergence 4th Annual Crypto, FinTech, AI & Energy Infrastructure Conference
Published on 11/09/2026 at 22:05, 4 hours 49 minutes ago

Mayr-Melnhof Karton AG: MM Group to sell majority stake in its Packaging business to KPS Capital Partners and plans a special distribution to shareholders

View all EQS

Published on 11/09/2026 at 18:30, 8 hours 24 minutes ago

Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 18:30, 8 hours 24 minutes ago

Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 390 millions de CHF
Published on 11/09/2026 at 17:45, 9 hours 9 minutes ago

Weekly share buyback
Published on 11/09/2026 at 17:45, 9 hours 9 minutes ago

Déclaration hebdomadaire de rachat d'actions
Published on 11/09/2026 at 17:45, 9 hours 9 minutes ago

Déclaration des droits de vote à fin octobre 2026

View all LES ECHOS COMFI WIRE

News